Danaher Tests Support Before Q4, $261 in Sight
$Danaher(DHR)$
Danaher Corp(DHR) Retreats -2.11%: Key Support Test Ahead of Earnings, Eyes $261 Target
📈 Latest Close Data
Closed at $235.01 (Jan 26), down -2.11%. Currently ~9% below its 52-week high of $258.23.
🚀 Core Market Drivers
-
Earnings Anticipation: The stock pulled back ahead of its Q4/FY25 earnings report scheduled for Jan 28. Management had previously guided for results at the high end of expectations.
-
Sector M&A Buzz: News of potential sale talks at peer Qiagen (QGEN) stirred the life sciences sector, reminding investors of the ongoing industry consolidation where Danaher is a key player.
📊 Technical Analysis
-
Volume: 3.07M shares traded, with a volume ratio of 0.80, indicating subdued activity.
-
MACD: Latest reading is -0.36, with DIF (2.91) below DEA (3.14), signaling a bearish momentum shift in the very short term.
-
RSI (6): At 44.24, it's dipped from overbought levels, showing the sell-off but not yet in oversold territory. A move below 40 could signal further downside.
🎯 Key Price Levels
-
Primary Support: $224.83 (Jan 23 low). A break below could trigger a deeper correction.
-
Strong Resistance: $258.23 (52-week high). The key level to watch for a bullish breakout.
-
Immediate Pivot: $236.63 (Recent resistance). Needs to be reclaimed for any near-term bullish momentum.
💰 Valuation Perspective
-
Forward P/E: 27.90, which is slightly below its historical average of 28.74. This suggests the recent pullback has brought valuation to a more reasonable level relative to its own history.
🎯 Analyst Targets
-
27 analysts cover the stock.
-
Average Price Target: $261.74, implying a ~11% upside from current levels.
-
Sentiment: Overwhelmingly positive, with 11 Strong Buy, 13 Buy, and only 3 Hold ratings.
🔮 Weekly Outlook
Expect consolidation between $224 - $245 ahead of earnings. A positive earnings surprise could fuel a rally towards the $261 analyst target. Conversely, a break below $224 support could see a test of the $215-$220 zone.
⚠️ Risk Disclaimer
This analysis is for informational purposes only and not financial advice. Investing involves risks, including the potential loss of principal. Past performance is not indicative of future results. Always conduct your own research and consider your financial situation before trading.
For SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with unlimited trading on SG, HK, and US stocks, as well as ETFs.
🎉Cash Boost Account Now Supports 35,000+ Stocks & ETFs – Greater Flexibility Now
Find out more here.
Complete your first Cash Boost Account trade with a trade amount of ≥ SGD1000* to get SGD 688 stock vouchers*! The trade can be executed using any payment type available under the Cash Boost Account: Cash, CPF, SRS, or CDP.
Other helpful links:
-
💰Join the TB Contra Telegram Group to Get $10 Trading Vouchers Now🎉
-
How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
